Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes or heart failure

Yi Wang1, Quirino Ciampi2, Lauro Cortigiani3

  • 1Department of Cardiovascular Ultrasound and Non-Invasive Cardiology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Chengdu, China.

Insights

Hypercontractile phenotype (HP) of the left ventricle is linked to older age, female sex, and high blood pressure. Recognizing HP is key for treating heart conditions like chronic coronary syndromes and heart failure.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • The hypercontractile phenotype (HP) of the left ventricle (LV) is a significant therapeutic target in patients with chronic coronary syndromes (CCS) or heart failure (HF).
  • Clinical recognition of HP remains challenging, necessitating identification of associated clinical variables.

Purpose of the Study:

  • To identify clinical variables associated with the hypercontractile phenotype (HP) of the left ventricle (LV).

Main Methods:

  • A prospective, observational, multicenter study involving 5122 patients with CCS and/or HF with preserved ejection fraction (EF).
  • Assessment of systolic blood pressure (SBP), wall motion score index (WMSI), LV volumes (EDV, ESV), EF, force (SBP/ESV), stroke volume (SV), arterial elastance (SBP/SV), and ventricular-arterial coupling (VAC).
  • Univariable and multivariable logistic regression analysis to determine factors associated with the highest force sextile.

Main Results:

  • The highest force sextile was significantly associated with advanced age (>65 years), hypertension, female sex, absence of beta-blocker therapy, high resting SBP (≥160 mmHg), high heart rate, and absence of prior myocardial infarction.
  • Patients in the highest force sextile exhibited lower WMSI, SV, EDV, and ESV, alongside higher arterial elastance and VAC.
  • Echocardiographic findings in HP included a small LV with reduced EDV and SV, despite a high EF, and elevated arterial elastance.

Conclusions:

  • The hypercontractile phenotype (HP) of the left ventricle is clinically associated with specific patient characteristics, including advanced age, female sex, high resting systolic blood pressure, and lack of beta-blocker therapy.
  • HP is characterized by reduced LV volumes and stroke volume despite preserved ejection fraction, coupled with increased arterial elastance.
  • These findings aid in the clinical recognition and potential therapeutic targeting of HP in cardiovascular disease management.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
594